MGNX vs NEM · rev $39.6M vs P/E 14, rev $13.43B
MacroGenics Inc (MGNX) versus Newmont Goldcorp Corp (NEM) — a side-by-side from cached financials, not a winner call.
MacroGenics Inc (MGNX) is a biotechnology company listed on NASDAQ.
Newmont Goldcorp Corp (NEM) is a gold company listed on NYSE.
Latest reported MGNX revenue for 2026-06-30 was $39.6M. Net income was -$17.3M. Revenue was up 90.4% from 2026-03-31 to 2026-06-30. MGNX currently screens at market cap $246.6M.
Latest reported NEM revenue for 2026-06-30 was $13.43B. Net income was $5.46B. Revenue was up 83.7% from 2026-03-31 to 2026-06-30. NEM currently screens at market cap $112.81B and trailing P/E 13.7.
MGNX currently screens at market cap $246.6M. NEM currently screens at market cap $112.81B and trailing P/E 13.7.
Not investment advice. Open the MGNX and NEM stock pages for the full models.
Not investment advice.